Narges Sangtarash
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Narges Sangtarash has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Amin Abbasi
Department of Food Science and Technology, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Atefeh Karimi
Department of Food Safety and Hygiene, School of Public Health, Zanjan University of Medical Sciences, Zanjan, Iran
1 shared publication - Aziz Homayouni Rad
Department of Food Science and Technology, Faculty of Nutrition & Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Hedayat Hosseini
Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Science and Food Technology Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication - Leili Aghebati-Maleki
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
1 shared publication - Lena Motalebi
Department of Physical Education and Sport Sciences, Sho.C., Islamic Azad University, shoushtar, Iran
1 shared publication
Latest Publications
- Open Access
- 5 August 2026
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 28 (4) , e171871
Effects of Continuous and Interval Aerobic Exercise on MicroRNA-146a and MicroRNA-126 Levels in Women with Atherosclerosis
Background: Atherosclerosis is a chronic inflammatory vascular disease characterized by endothelial dysfunction and altered expression of regulatory microRNAs. Among these, microRNA-126 (miR-126) and microRNA-146a (miR-146a) play important roles in angiogenesis, endothelial repair, and the modulation of inflammatory pathways. Objectives: This study investigated the effects of moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT) on circulating levels of miR-126 and miR-146a in women with atherosclerosis. Methods: In this randomized controlled trial, 45 women with clinically diagnosed atherosclerosis were randomly assigned to the control, MICT, or HIIT group (n = 15 each). Exercise interventions were performed three times per week for 12 weeks. Blood samples were collected at baseline and after 6 and 12 weeks. Circulating miR-126 and miR-146a expression levels were measured using quantitative real-time PCR (qRT-PCR). Other cardiovascular and physiological variables were assessed for safety and participant characterization purposes and were not predefined efficacy endpoints. Data were analyzed using linear mixed models with Bonferroni post hoc tests. Results: Significant time × group interactions were observed for both miR-146a (F = 35.5, P < 0.001, η = 0.53) and miR-126 (F = 33.1, P < 0.001, η = 0.52). Both HIIT and MICT significantly increased circulating levels of miR-146a and miR-126 compared with those in the control group (P < 0.001). Although the overall increases after 12 weeks were comparable between the exercise modalities, HIIT induced earlier elevations in both microRNAs during the first 6 weeks, whereas MICT produced a more gradual but sustained increase during the latter phase of the intervention. Conclusions: Twelve weeks of aerobic exercise increased circulating miR-126 and miR-146a in women with atherosclerosis. Although both training modalities produced similar long-term benefits, HIIT elicited more rapid molecular adaptations. These findings suggest that aerobic exercise may promote vascular health through favorable epigenetic modulation and support the use of individualized exercise prescriptions for cardiovascular rehabilitation.
- 5 August 2026
- Published by Brieflands in Zahedan Journal of Research in Medical Sciences
- Vol. 28 (4) , e171871
Open AccessEffects of Continuous and Interval Aerobic Exercise on MicroRNA-146a and MicroRNA-126 Levels in Women with Atherosclerosis
Background: Atherosclerosis is a chronic inflammatory vascular disease characterized by endothelial dysfunction and altered expression of regulatory microRNAs. Among these, microRNA-126 (miR-126) and microRNA-146a (miR-146a) play important roles in angiogenesis, endothelial repair, and the modulation of inflammatory pathways. Objectives: This study investigated the effects of moderate-intensity continuous training (MICT) and high-intensity interval training (HIIT) on circulating levels of miR-126 and miR-146a in women with atherosclerosis. Methods: In this randomized controlled trial, 45 women with clinically diagnosed atherosclerosis were randomly assigned to the control, MICT, or HIIT group (n = 15 each). Exercise interventions were performed three times per week for 12 weeks. Blood samples were collected at baseline and after 6 and 12 weeks. Circulating miR-126 and miR-146a expression levels were measured using quantitative real-time PCR (qRT-PCR). Other cardiovascular and physiological variables were assessed for safety and participant characterization purposes and were not predefined efficacy endpoints. Data were analyzed using linear mixed models with Bonferroni post hoc tests. Results: Significant time × group interactions were observed for both miR-146a (F = 35.5, P < 0.001, η = 0.53) and miR-126 (F = 33.1, P < 0.001, η = 0.52). Both HIIT and MICT significantly increased circulating levels of miR-146a and miR-126 compared with those in the control group (P < 0.001). Although the overall increases after 12 weeks were comparable between the exercise modalities, HIIT induced earlier elevations in both microRNAs during the first 6 weeks, whereas MICT produced a more gradual but sustained increase during the latter phase of the intervention. Conclusions: Twelve weeks of aerobic exercise increased circulating miR-126 and miR-146a in women with atherosclerosis. Although both training modalities produced similar long-term benefits, HIIT elicited more rapid molecular adaptations. These findings suggest that aerobic exercise may promote vascular health through favorable epigenetic modulation and support the use of individualized exercise prescriptions for cardiovascular rehabilitation.
- Top Cited Papers
- 29 March 2022
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 63 (26) , 8375-8402
Postbiotics as the new frontier in food and pharmaceutical research
Food is the essential need of human life and has nutrients that support growth and health. Gastrointestinal tract microbiota involves valuable microorganisms that develop therapeutic effects and are characterized as probiotics. The investigations on appropriate probiotic strains have led to the characterization of specific metabolic byproducts of probiotics named postbiotics. The probiotics must maintain their survival against inappropriate lethal conditions of the processing, storage, distribution, preparation, and digestion system so that they can exhibit their most health effects. Conversely, probiotic metabolites (postbiotics) have successfully overcome these unfavorable conditions and may be an appropriate alternative to probiotics. Due to their specific chemical structure, safe profile, long shelf-life, and the fact that they contain various signaling molecules, postbiotics may have anti-inflammatory, immunomodulatory, antihypertensive properties, inhibiting abnormal cell proliferation and antioxidative activities. Consequently, present scientific literature approves that postbiotics can mimic the fundamental and clinical role of probiotics, and due to their unique characteristics, they can be applied in an oral delivery system (pharmaceutical/functional foods), as a preharvest food safety hurdle, to promote the shelf-life of food products and develop novel functional foods or/and for developing health benefits, and therapeutic aims. This review addresses the latest postbiotic applications with regard to pharmaceutical formulations and commercial food-based products. Potential postbiotic applications in the promotion of host health status, prevention of disease, and complementary treatment are also reviewed.
- 29 March 2022
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 63 (26) , 8375-8402
Top Cited PapersPostbiotics as the new frontier in food and pharmaceutical research
Food is the essential need of human life and has nutrients that support growth and health. Gastrointestinal tract microbiota involves valuable microorganisms that develop therapeutic effects and are characterized as probiotics. The investigations on appropriate probiotic strains have led to the characterization of specific metabolic byproducts of probiotics named postbiotics. The probiotics must maintain their survival against inappropriate lethal conditions of the processing, storage, distribution, preparation, and digestion system so that they can exhibit their most health effects. Conversely, probiotic metabolites (postbiotics) have successfully overcome these unfavorable conditions and may be an appropriate alternative to probiotics. Due to their specific chemical structure, safe profile, long shelf-life, and the fact that they contain various signaling molecules, postbiotics may have anti-inflammatory, immunomodulatory, antihypertensive properties, inhibiting abnormal cell proliferation and antioxidative activities. Consequently, present scientific literature approves that postbiotics can mimic the fundamental and clinical role of probiotics, and due to their unique characteristics, they can be applied in an oral delivery system (pharmaceutical/functional foods), as a preharvest food safety hurdle, to promote the shelf-life of food products and develop novel functional foods or/and for developing health benefits, and therapeutic aims. This review addresses the latest postbiotic applications with regard to pharmaceutical formulations and commercial food-based products. Potential postbiotic applications in the promotion of host health status, prevention of disease, and complementary treatment are also reviewed.